Breast Cancer
Showing NaN - NaN of 215
Breast Cancer, Overweight or Obesity Trial in Baltimore (Contrave, Behavioral Weight Loss)
Recruiting
- Breast Cancer
- Overweight or Obesity
- Contrave
- Behavioral Weight Loss
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Nov 2, 2022
TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)
Active, not recruiting
- TNBC - Triple-Negative Breast Cancer
- Breast Cancer
- Trilaciclib
- +3 more
-
Birmingham, Alabama
- +111 more
Oct 25, 2022
Breast Cancer Trial in United States (NeuVax vaccine, Trastuzumab, GM-CSF)
Completed
- Breast Cancer
- NeuVax vaccine
- +2 more
-
Santa Monica, California
- +23 more
Sep 15, 2022
Breast Cancer Trial in Baltimore, Dallas (Dose Fractionation)
Active, not recruiting
- Breast Cancer
- Dose Fractionation
-
Baltimore, Maryland
- +1 more
Sep 7, 2022
Breast Cancer Trial in United States (gemcitabine HCl, imatinib mesylate)
Terminated
- Breast Cancer
- gemcitabine hydrochloride
- imatinib mesylate
-
Chicago, Illinois
- +8 more
Aug 12, 2022
Biomarkers in Subjects With Untreated Solid Tumors
Completed
- Breast Cancer
- +12 more
- Blood Sample Collection
-
Phoenix, Arizona
- +118 more
Aug 31, 2022
Mesothelioma, Glioblastoma, Renal Cell Carcinoma Trial in Korea, Republic of, Taiwan, United States (NGM707, NGM707 plus
Recruiting
- Mesothelioma
- +14 more
- NGM707
- NGM707 plus pembrolizumab
-
Los Angeles, California
- +13 more
Aug 16, 2022
Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Capecitabine, Lapatinib)
Active, not recruiting
- Breast Cancer
- Trastuzumab deruxtecan
- +3 more
-
Chandler, Arizona
- +226 more
Aug 11, 2022
Breast Cancer Trial in Baltimore (Patient navigator support)
Recruiting
- Breast Cancer
- Patient navigator support
-
Baltimore, MarylandJohns Hopkins Breast Imaging clinics
Jul 28, 2022
Breast Cancer Trial in Baltimore (Endocrine Therapy and a CDK 4/6 inhibitor)
Recruiting
- Breast Cancer
- Endocrine Therapy and a CDK 4/6 inhibitor
-
Baltimore, MarylandJohns Hopkins University
Jul 18, 2022
Advanced Malignant Tumor, Breast Cancer, Ovarian Cancer Trial in United States (AMXI-5001:Dose Escalation Phase I,
Recruiting
- Advanced Malignant Neoplasm
- +5 more
- AMXI-5001:Dose Escalation Phase I
- AMXI-5001:Dose Expansion Phase II
-
Phoenix, Arizona
- +7 more
Jul 18, 2022
Breast Cancer Trial in Worldwide (Ribociclib, Letrozole, Goserelin)
Breast Cancer, Head Neck Cancer, Squamous Cell Carcinoma Trial in Canada, United States (INT230-6, anti-PD-1 antibody,
Active, not recruiting
- Breast Cancer
- +10 more
- INT230-6
- +2 more
-
Los Angeles, California
- +7 more
Jun 21, 2022
Breast Cancer Trial in United States (therapeutic conventional surgery, whole breast irradiation)
Active, not recruiting
- Breast Cancer
- therapeutic conventional surgery
- whole breast irradiation
-
Hot Springs, Arkansas
- +349 more
Jun 16, 2022
Breast Cancer, Early-stage Breast Cancer Trial in Baltimore (Prescreening, Screening and Enrollment, Baseline)
Recruiting
- Breast Cancer
- Early-stage Breast Cancer
- Prescreening
- +8 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jun 16, 2022
Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer Trial in Washington, Baltimore (Simvastatin,
Active, not recruiting
- Breast Cancer
- +3 more
-
Washington, District of Columbia
- +1 more
May 19, 2022
Breast Cancer Trial in United States (Lapatinib, Letrozole, Trastuzumab)
Breast Cancer Trial in Baltimore (Anastrozole, Letrozole)
Recruiting
- Breast Cancer
-
Baltimore, MarylandUniversity of Maryland Greenebaum Cancer Center
Apr 29, 2022
Johns Hopkins Breast Cancer Program Hormone Therapy Longitudinal
Active, not recruiting
- Breast Cancer
- Sample collection
- Patient-reported outcomes
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Apr 21, 2022